M A Perricone

Summary

Publications

  1. ncbi request reprint Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium
    M A Perricone
    Genzyme Corporation, Framingham, MA 01701, USA michael
    Hum Gene Ther 12:1383-94. 2001
  2. pmc E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors
    D Armentano
    Genzyme Corporation, Framingham, Massachusetts 01701 9322, USA
    J Virol 73:7031-4. 1999
  3. ncbi request reprint Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells
    M A Perricone
    Genzyme, Framingham, MA 01701, USA
    Hum Gene Ther 11:1997-2008. 2000

Detail Information

Publications3

  1. ncbi request reprint Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium
    M A Perricone
    Genzyme Corporation, Framingham, MA 01701, USA michael
    Hum Gene Ther 12:1383-94. 2001
    ....
  2. pmc E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors
    D Armentano
    Genzyme Corporation, Framingham, Massachusetts 01701 9322, USA
    J Virol 73:7031-4. 1999
    ..CMV promoter truncation led to the persistence of expression in the absence of E4, thus eliminating the ORF3 requirement...
  3. ncbi request reprint Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells
    M A Perricone
    Genzyme, Framingham, MA 01701, USA
    Hum Gene Ther 11:1997-2008. 2000
    ..We conclude that preexisting adenovirus-specific antibodies present in some of the patient samples were the predominant factor inhibiting Ad-mediated gene transfer...